Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit frontier cancer targets, today announced the publication of an original scientific paper in the Proceedings of the National Academy of Sciences.
5/22/20: Congratulations to Anna Day on her BioSURF award! The Washington University Biology Summer Undergraduate Research Fellowship Program (BioSURF) introduces WashU undergraduate students to research in the life-sciences under the guidance of WashU faculty mentors. BioSURF is competitive and is modeled on the grant-seeking process, with faculty from the WashU Biology Department and Medical School […]
JBC’s Early Career Reviewer (ECR) Board is designed to involve scientists at early stages of their careers in peer review, creating a structured path for developing relevant skills and learning about the scientific publishing process. We are thrilled to offer these up-and-coming scientists an opportunity to gain first-hand experience in the peer review process and […]
In collaboration with Mustafa Icel from the Gateway Science Academy (GSA) in St. Louis, Arpita Bose along with Hani Zaher and Josh Blodgett started a high School Partnership with WUSTL Biology called the Gateway Science Summer Program. This partnership supports funded research for St. Louis City high school students to experience what it feels like to work in a “real” lab.
Dr. Blodgett sat down with the Ampersand to talk about how he integrates his industry background into his teaching and research. He shares his early memories on what sparked his interests in microbiology. Dr. Blodgett and his research team are on a mission to find the next antibiotics to fight the super bugs.
Across eastern North America, White-nose syndrome has become a significant cause of mortality for many bat species. In addition to their role as key members of delicate, nutrient-poor cave ecosystems, bats provide up to $53 billion in yearly protection of cropland by via consumption of insect pests.